Letter to the editor: reply to Legare et al

Med Hypotheses. 2014 Sep;83(3):418. doi: 10.1016/j.mehy.2014.05.023. Epub 2014 Jun 23.

Authors

R van Westrhenen¹, P F J Schulte², I Sommer³

Affiliations

¹ Department of Psychiatry, Brain Center Rudolf Magnus, UMC, Utrecht, The Netherlands. Electronic address: [email protected].
² Dept. for Specialized treatments, Center for Bipolar Disorders, Alkmaar, The Netherlands.
³ Department of Psychiatry, Brain Center Rudolf Magnus, UMC, Utrecht, The Netherlands.

PMID: 25012779
DOI: 10.1016/j.mehy.2014.05.023

No abstract available

Publication types

Letter
Comment

MeSH terms

Clozapine / analogs & derivatives*
Clozapine / therapeutic use*
Fluvoxamine / therapeutic use*
Humans
Schizophrenia / drug therapy*

Substances

Clozapine
Fluvoxamine